Acorda Therapeutics (ACOR) Stock Price, News & Analysis

Acorda Therapeutics saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 8,100 shares, a drop of 14.7% from the March 15th total of 9,500 shares. Based on an average daily trading volume, of 113,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.7% of the company's shares are sold short.
View Acorda Therapeutics' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our ACOR earnings forecast.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) posted its quarterly earnings data on Tuesday, November, 9th. The biopharmaceutical company reported ($28.60) earnings per share (EPS) for the quarter, topping the consensus estimate of ($31.20) by $2.60. The biopharmaceutical company had revenue of $31.46 million for the quarter, compared to analysts' expectations of $30.57 million. Acorda Therapeutics had a negative net margin of 214.95% and a negative trailing twelve-month return on equity of 2,206.93%.

Acorda Therapeutics shares reverse split on the morning of Monday, June 5th 2023. The 1-20 reverse split was announced on Monday, June 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

39 employees have rated Acorda Therapeutics Chief Executive Officer Ron Cohen on Glassdoor.com. Ron Cohen has an approval rating of 55% among the company's employees. This puts Ron Cohen in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Acorda Therapeutics investors own include Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), ADMA Biologics (ADMA), InterDigital (IDCC), Nektar Therapeutics (NKTR), Rigel Pharmaceuticals (RIGL), Novan (NOVN), SCYNEXIS (SCYX), Acasti Pharma (ACST) and Applied Materials (AMAT).

Shares of ACOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.